Clinical use of heparin-coated cardiopulmonary bypass in coronary artery bypass grafting

Thoracic and Cardiovascular Surgeon

Volumn 49, Issue 3, 2001, Pages 131-136

  Mirow, N ^a   Minami, K ^a   Kleikamp, G ^a   Tenderich, G ^a   Puhlmann, T ^a   Korfer R ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cardiopulmonary bypass; Coronary bypass surgery; Extracorporeal circulation; Heparin coating; Low molecular weight heparin; Systemic heparinization

Indexed keywords

BREVYMITAL; ENFLURANE; FENTANYL; FENTANYL DERIVATIVE; LORMETAZEPAM; LOW MOLECULAR WEIGHT HEPARIN; METHOHEXITAL; MORPHINE; ROCURONIUM; SUXAMETHONIUM;

ADULT; AGED; BIOCOMPATIBILITY; BLOOD CLOTTING TIME; BLOOD SUBSTITUTION; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG COATING; EXTRACORPOREAL CIRCULATION; FEMALE; HEMOSTASIS; HEPARINIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; THROMBOEMBOLISM;

ADULT; AGED; ANTICOAGULANTS; CARDIOPULMONARY BYPASS; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; KIDNEY FAILURE; LENGTH OF STAY; MIDDLE AGED; MYOCARDIAL INFARCTION; PARESIS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROTAMINES;

EID: 0034808242     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-14287     Document Type: Conference Paper

References (28)

1. Extracorporeal perfusion
2. Inflammatory response to cardiopulmonary bypass
3. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study
4. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits
5. Heparin coated oxygenators significantly reduce contact system activation in an in vitro cardiopulmonary bypass model
6. Risk and benefit of low systemic heparinization during open heart operations
7. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: Clinical and hemostatic effects
8. Pathway of platelet protection in heparin-coated devices and its significance for cardiac surgery
9. Complement activation during cardiopulmonary bypass: Effects of immobilized heparin
10. Surface bound heparin - Panacea or peril?
11. Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation
12. Inhibition of platelet function by heparin. An etiologic factor in postoperative hemorrhage
13. Clinical application of heparin-coated perfusion equipment with special emphasis on patients refusing homologous transfusions
14. Reduction and elimination of systemic heparinization during cardiopulmonary bypass
15. Inflammatory response to cardiopulmonary bypass
16. Heparin-coated cardiopulmonary bypass circuits
17. Heparinbeschichtete Systeme
18. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue
19. The heparin-protamine interaction
20. Protamine-induced hypotension in heart operations: Application of the concept of ventricular-arterial coupling
21. Inflammatory mediators in adults undergoing cardiopulmonary bypass: Comparison of centrifugal and roller pumps
22. Clinical evaluation of Duraflo II heparin treated extracorporeal circulation circuits (2nd version). The European working group on heparin coated extracorporeal circulation circuits
23. Stroke associated with cardiac surgery: Determinants, timing and stroke subtypes
24. Adverse cerebral outcomes after coronary bypass surgery
25. Clinical outcome after coronary surgery with heparin-coated extracorporeal circuits for cardiopulmonary bypass
26. Heparin-coated Cardiopulmonary bypass circuits: Hemostatic alterations and postoperative blood loss
27. Clinical effects of the heparin coated surface in cardiopulmonary bypass
28. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: A prospective, randomized study